FR EA

Contract analysis

Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.

Contract analysis / board-update-memo.docx
board-update-memo.docx
1042-00003 · 22 clauses
High · 8 Medium · 2 Standard · 3
I. Executive Summary High
⚑ Non-compete / exclusivity restraint
I. Executive Summary Calderwood & Harkness LLP provides this privileged memorandum to update the board of directors, executive leadership, and senior management of Brightfield Cloud Services Inc. ("Brightfield"), together with Vantage Summit Capital Partners, LP ("Vantage Summit"), Brightfield's majority equity holder (board observer: Graham Hollister), on the current status of the proposed exclusive technology licen
II. Background and Parties High
⚑ Non-compete / exclusivity restraint
II. Background and Parties A. Brightfield Cloud Services Inc. Brightfield Cloud Services Inc. is a Delaware corporation headquartered at 4200 Bluebonnet Parkway, Suite 1100, Austin, Texas 78745. Brightfield operates as an enterprise SaaS platform and hybrid-cloud hardware appliance company, offering the "Stratos" cloud-management platform to mid-market and enterprise customers across multiple industry verticals. The
III. Proposed Deal Terms High
⚑ Non-compete / exclusivity restraint
III. Proposed Deal Terms The following summarizes the principal commercial terms of the proposed Technology License Agreement as they currently stand, reflecting the points of agreement reached during the negotiation process. The critical unresolved issue — the scope of the permitted field of use — is addressed separately in Section V. A. License Fee Structure The parties have agreed in principle on an aggregate lice
IV. Negotiation Timeline High
⚑ Non-compete / exclusivity restraint
IV. Negotiation Timeline Set forth below is a chronological summary of the key events and milestones in the negotiation of the DeltaSync Technology License Agreement from the opening of the engagement through the date of this memorandum. June 8, 2023 — Calderwood & Harkness LLP engagement opened. Engagement letter executed by Daniel Oshiro, General Counsel of Brightfield. Matter number 1042-00003 assigned. Billing co
V. The Field-of-Use Impasse High
⚑ Non-compete / exclusivity restraint
V. The Field-of-Use Impasse The field-of-use issue has emerged as the single most significant obstacle to completion of the DeltaSync license transaction. Despite extensive negotiation across multiple drafts and dedicated term-sheet exchanges, the parties remain fundamentally apart on the scope of the industry verticals in which Brightfield would be permitted to deploy the DeltaSync technology. This section describes
1. Industry-Agnostic Platform Architecture. The Stratos platform is designed and marketed
1. Industry-Agnostic Platform Architecture. The Stratos platform is designed and marketed as an industry-agnostic cloud-management solution. Brightfield's go-to-market strategy, sales organization, and product roadmap are not organized around industry verticals. Restricting a core platform capability (distributed-cache orchestration) to only two verticals would be inconsistent with the fundamental product architectur
2. Addressable Revenue Limitation. Brightfield's financial analysis indicates that the fi Standard
⚑ Commercial term
2. Addressable Revenue Limitation. Brightfield's financial analysis indicates that the financial services and healthcare verticals together represent approximately Thirty-Eight Million Dollars ($38,000,000) in ARR — approximately 26.8% of Brightfield's total ARR of $142,000,000. At this level of addressable revenue, the $8,000,000 license fee cannot be commercially justified. The per-unit cost of the DeltaSync techno
3. Cross-Vertical Growth Strategy. Vantage Summit Capital Partners' investment thesis for High
⚑ Non-compete / exclusivity restraint
3. Cross-Vertical Growth Strategy. Vantage Summit Capital Partners' investment thesis for Brightfield contemplates expansion of the Stratos platform across all enterprise verticals. Accepting a narrow field-of-use restriction would be inconsistent with this growth plan and would effectively preclude Brightfield from deploying a material competitive differentiator for the majority of its customer base. C. Brightfield'
VI. Legal and Strategic Analysis High
⚑ Non-compete / exclusivity restraint
VI. Legal and Strategic Analysis A. Commercial Impact of Narrow Field of Use The commercial implications of accepting a DeltaSync license restricted to the financial services and healthcare verticals are significant and, in Calderwood & Harkness's assessment, substantially undermine the business case for the transaction. If the license is restricted to financial services (SIC codes 6000–6799) and healthcare (SIC code
VII. Scheduled Final Negotiation Call — September 14, 2023
VII. Scheduled Final Negotiation Call — September 14, 2023 A final negotiation call between the principals and counsel for both parties is scheduled for September 14, 2023. The purpose of this call is to determine whether any path to agreement on field-of-use terms exists, or whether the parties must conclude that the transaction cannot be completed on mutually acceptable terms. The following individuals are expected
VIII. Recommendation
VIII. Recommendation Based on the analysis set forth in this memorandum, Calderwood & Harkness LLP makes the following recommendations to the Brightfield board and executive leadership:
1. Enter the September 14 call prepared to terminate. Brightfield should enter the Septemb
1. Enter the September 14 call prepared to terminate. Brightfield should enter the September 14, 2023 final negotiation call fully prepared to terminate the transaction if the field-of-use impasse is not resolved on that call. The negotiation team should not signal a willingness to continue open-ended discussions or to accept the narrow field-of-use restriction as a basis for further negotiation.
2. Define acceptable outcomes. Specifically, Calderwood & Harkness recommends that Brightf Standard
⚑ Commercial term
2. Define acceptable outcomes. Specifically, Calderwood & Harkness recommends that Brightfield communicate to Nexilis that only two outcomes are acceptable: (a) Nexilis agrees to an unrestricted enterprise SaaS field of use at the originally proposed aggregate license fee of Eight Million Dollars ($8,000,000); or (b) Nexilis agrees to the tiered-unlock structure at an aggregate consideration of Ten Million Dollars ($
3. Terminate if impasse persists. If Nexilis is unwilling to agree to either of the forego
3. Terminate if impasse persists. If Nexilis is unwilling to agree to either of the foregoing outcomes, Calderwood & Harkness's recommendation is to close the matter and terminate negotiations. Continued negotiation in the absence of a realistic path to agreement on the field-of-use issue would not be a productive use of Brightfield's management time, legal resources, or negotiating capital.
4. Post-termination steps. Upon termination of the transaction, Calderwood & Harkness will Medium
⚑ Confidentiality undertaking
4. Post-termination steps. Upon termination of the transaction, Calderwood & Harkness will: (a) Issue a formal closing letter to Whitmore & Falk confirming the termination of negotiations; (b) Coordinate the return and destruction of confidential information exchanged between the parties under the NDA (executed June 19, 2023), in accordance with the NDA's provisions governing the treatment of confidential information
5. Fees and disbursements to date. For the board's awareness, Calderwood & Harkness has, t Standard
⚑ Commercial term
5. Fees and disbursements to date. For the board's awareness, Calderwood & Harkness has, through the date of this memorandum, billed professional fees of $197,450 and disbursements of $42,500 (representing the Crestline Patent Analytics LLC engagement for the freedom-to-operate and patent landscape analysis), for a total of $239,950. This amount is within the range of the original fee estimate provided at the commenc
IX. Requested Board Actions
IX. Requested Board Actions Calderwood & Harkness respectfully requests that the Brightfield board take the following actions in connection with this memorandum:
1. Authorize participation in the September 14 call. Authorize Daniel Oshiro (General Cou
1. Authorize participation in the September 14 call. Authorize Daniel Oshiro (General Counsel) and Lisa Redmond (VP, Corporate Development & Strategy) to participate in the September 14, 2023 final negotiation call with Nexilis, with instructions consistent with the recommendations set forth in Section VIII of this memorandum — specifically, authority to present the two acceptable outcomes (unrestricted field of use
2. Authorize termination of negotiations. Authorize Brightfield management to terminate n
2. Authorize termination of negotiations. Authorize Brightfield management to terminate negotiations with Nexilis and close the matter if the field-of-use impasse cannot be resolved on the September 14 call on terms consistent with this memorandum.
3. Direct preparation of internal build alternative. Direct Marcus Vail, Chief Technology
3. Direct preparation of internal build alternative. Direct Marcus Vail, Chief Technology Officer, to prepare a preliminary project plan, timeline, and cost estimate for an internal build of distributed-cache orchestration functionality comparable to DeltaSync, to be presented to the board in the event that the DeltaSync license transaction is not consummated. Calderwood & Harkness recommends that this project plan b
4. Acknowledge receipt and confirm limited distribution. Acknowledge receipt of this priv Medium
⚑ Liability cap to check against exposure
4. Acknowledge receipt and confirm limited distribution. Acknowledge receipt of this privileged attorney-client memorandum and confirm that distribution has been limited to the named addressees — Priya Chandrasekaran, Daniel Oshiro, and Graham Hollister. This memorandum is protected by the attorney-client privilege and the attorney work product doctrine, and its privileged status may be waived by disclosure to person
X. Contact Information High
⚑ Non-compete / exclusivity restraint
X. Contact Information We are available to discuss any aspect of this memorandum or the DeltaSync license negotiation at your convenience. The following members of the Calderwood & Harkness engagement team may be contacted directly: Catherine Bloom Partner, intellectual Property Calderwood & Harkness LLP 700 Louisiana Street, Suite 3400 Houston, TX 77002 Direct: (713) 555-4821 Email: cbloom@calderwoodharkness.com Res